SE302127B - - Google Patents
Info
- Publication number
- SE302127B SE302127B SE225463A SE225463A SE302127B SE 302127 B SE302127 B SE 302127B SE 225463 A SE225463 A SE 225463A SE 225463 A SE225463 A SE 225463A SE 302127 B SE302127 B SE 302127B
- Authority
- SE
- Sweden
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17690162A | 1962-03-02 | 1962-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE302127B true SE302127B (de) | 1968-07-08 |
Family
ID=22646360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE225463A SE302127B (de) | 1962-03-02 | 1963-03-01 |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE629005A (de) |
| BR (1) | BR6347108D0 (de) |
| CH (3) | CH438336A (de) |
| CY (1) | CY418A (de) |
| DE (1) | DE1445874A1 (de) |
| GB (2) | GB1040547A (de) |
| MY (1) | MY6800032A (de) |
| SE (1) | SE302127B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5218114A (en) * | 1991-04-10 | 1993-06-08 | Merck & Co., Inc. | Cholecystokinin antagonists |
| DE19503320A1 (de) * | 1995-02-02 | 1996-08-08 | Boehringer Mannheim Gmbh | Neue Benzodiazepinkonjugate |
-
1963
- 1963-02-20 BR BR14710863A patent/BR6347108D0/pt unknown
- 1963-02-22 CH CH231263A patent/CH438336A/de unknown
- 1963-02-22 CH CH5067A patent/CH455815A/de unknown
- 1963-02-22 CH CH1370566A patent/CH454887A/de unknown
- 1963-02-25 DE DE19631445874 patent/DE1445874A1/de active Pending
- 1963-02-28 BE BE629005A patent/BE629005A/fr unknown
- 1963-03-01 GB GB823863A patent/GB1040547A/en not_active Expired
- 1963-03-01 SE SE225463A patent/SE302127B/xx unknown
- 1963-03-01 GB GB4791164A patent/GB1040548A/en not_active Expired
-
1967
- 1967-11-30 CY CY41867A patent/CY418A/xx unknown
-
1968
- 1968-12-31 MY MY6800032A patent/MY6800032A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH438336A (de) | 1967-06-30 |
| CH454887A (de) | 1968-04-30 |
| GB1040547A (en) | 1966-09-01 |
| DE1445874A1 (de) | 1970-07-23 |
| CY418A (en) | 1967-11-30 |
| BE629005A (fr) | 1963-08-28 |
| GB1040548A (en) | 1966-09-01 |
| BR6347108D0 (pt) | 1973-07-19 |
| MY6800032A (en) | 1968-12-31 |
| CH455815A (de) | 1968-05-15 |